Inhibition of hepatic gluconeogenesis by phenethylhydrazine (phenelzine).
D000409:Alanine / Q000378:metabolism; D000818:Animals; D001219:Aspartate Aminotransferases / Q000037:antagonists & inhibitors; D005943:Gluconeogenesis / Q000187:drug effects*; D006835:Hydrazones / Q000378:metabolism; D066298:In Vitro Techniques; D007651:Keto Acids / Q000378:metabolism; D007659:Ketones / Q000096:biosynthesis; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D010084:Oxidation-Reduction; D010624:Phenelzine / Q000378:metabolism / Q000494:pharmacology*; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000037:antagonists & inhibitors; D011766:Pyruvate Carboxylase / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D014508:Urea / Q000096:biosynthesis
D006835:Hydrazones; D007651:Keto Acids; D007659:Ketones; D011773:Pyruvates; D009243:NAD; D014508:Urea; D001219:Aspartate Aminotransferases; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D011766:Pyruvate Carboxylase; D010624:Phenelzine; D000409:Alanine